Exscien Corporation is awarded support under the Commercialization Assistance Program (CAP) for NIH SBIR and STTR Phase II awardees.

This program is designed to help NIH Phase II awardees transition their SBIR-STTR-developed products into the marketplace by providing companies with individualized assistance toward accomplishing their regulatory and commercialization goals.